ADVERTISEMENT
COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

immunity, microbiology, disease & medicine

Patients Reinfected with Coronavirus in Hong Kong, Europe
Lisa Winter | Aug 25, 2020 | 2 min read
So far, there are three patients known to have been infected with SARS-CoV-2 twice, and in at least one case the second time around was asymptomatic.
COVID-19 Vaccine Developers Gain Enhanced Access to Supercomputers
Lisa Winter | Mar 27, 2020 | 2 min read
Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.
FDA to Allow for Plasma Therapy for COVID-19 Patients
Lisa Winter | Mar 26, 2020 | 3 min read
Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  
ADVERTISEMENT